
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
RETRACTION article
Front. Oncol., 26 October 2023
Sec. Pediatric Oncology
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1301668
This article is a retraction of:
RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
A Retraction of the Original Research Article
Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
by Lou L, Chen L, Wu Y, Zhang G, Qiu R, Su J, Zhao Z, Lu Z, Liao M and Deng X (2022) Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors. Front. Oncol. 12:982110. doi: 10.3389/fonc.2022.982110
The journal retracts the 21 October 2022 article cited above.
Following publication, concerns were raised regarding the use of the SK-NEP-1 cell line in the study to investigate Wilms’ tumor. An investigation, which was conducted in accordance with Frontiers’ policies, confirmed that the SK-NEP-1 cell line has been reclassified as belonging to the Ewing sarcoma family of tumors, rather than of Wilm’s tumor origin.
It was found that the complaint was valid, and that the scientific validity of the article cannot be confirmed; therefore, the article has been retracted.
This retraction was approved by the Chief Editor of Frontiers in Oncology - Pediatric Oncology and the Chief Executive Editor of Frontiers. We thank the reader for raising this concern.
Citation: Frontiers Editorial Office (2023) Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors. Front. Oncol. 13:1301668. doi: 10.3389/fonc.2023.1301668
Received: 25 September 2023; Accepted: 25 September 2023;
Published: 26 October 2023.
Approved by:
Jaume Mora, Sant Joan de Déu Hospital, SpainCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.